Research progress of traditional Chinese medicine in the treatment of ischemic stroke by regulating mitochondrial dysfunction
- PMID: 39251017
- DOI: 10.1016/j.lfs.2024.123045
Research progress of traditional Chinese medicine in the treatment of ischemic stroke by regulating mitochondrial dysfunction
Abstract
Ischemic stroke (IS) is a severe cerebrovascular disease with increasing incidence and mortality rates in recent years. The pathogenesis of IS is highly complex, with mitochondrial dysfunction playing a critical role in its onset and progression. Thus, preserving mitochondrial function is a pivotal aspect of treating ischemic brain injury. In response, there has been growing interest among scholars in the regulation of mitochondrial function through traditional Chinese medicine (TCM), including herb-derived compounds, individual herbs, and herbal prescriptions. This article reviews recent research on the mechanisms of mitochondrial dysfunction in IS and explores the potential of TCM in treating this condition by targeting mitochondrial dysfunction.
Keywords: Ischemic stroke; Mitochondrial dysfunction; Traditional Chinese medicine.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
[Research progress in mechanisms of herb pairs in treating ischemic stroke].Zhongguo Zhong Yao Za Zhi. 2025 Apr;50(8):2041-2049. doi: 10.19540/j.cnki.cjcmm.20250106.601. Zhongguo Zhong Yao Za Zhi. 2025. PMID: 40461217 Review. Chinese.
-
[Research progress in pathogenesis and traditional Chinese medicines treatment of ischemic stroke-related headache].Zhongguo Zhong Yao Za Zhi. 2023 Aug;48(16):4261-4274. doi: 10.19540/j.cnki.cjcmm.20230506.601. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37802853 Chinese.
-
Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanisms.Phytother Res. 2024 Jan;38(1):411-453. doi: 10.1002/ptr.8033. Epub 2023 Dec 5. Phytother Res. 2024. PMID: 38051175 Review.
-
Traditional medicine in China for ischemic stroke: bioactive components, pharmacology, and mechanisms.J Integr Neurosci. 2022 Jan 28;21(1):26. doi: 10.31083/j.jin2101026. J Integr Neurosci. 2022. PMID: 35164462 Review.
-
Pivotal regulatory roles of traditional Chinese medicine in ischemic stroke via inhibition of NLRP3 inflammasome.J Ethnopharmacol. 2022 Aug 10;294:115316. doi: 10.1016/j.jep.2022.115316. Epub 2022 May 2. J Ethnopharmacol. 2022. PMID: 35513214 Review.
Cited by
-
Mechanistic insights of neuronal death and neuroprotective therapeutic approaches in stroke.Neural Regen Res. 2026 Mar 1;21(3):869-886. doi: 10.4103/NRR.NRR-D-24-01324. Epub 2025 Apr 29. Neural Regen Res. 2026. PMID: 40313116 Free PMC article.
-
Insight of action mechanism of Astragaloside IV for relieving of cerebral ischemic injury in a rat model of middle cerebral artery occlusion reperfusion via proteomics and network pharmacology.J Nat Med. 2025 May;79(3):591-607. doi: 10.1007/s11418-025-01892-9. Epub 2025 Apr 10. J Nat Med. 2025. PMID: 40208491
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical